New depression drug tested in healthy volunteers for safety
NCT ID NCT07324408
First seen Jan 11, 2026 · Last updated May 24, 2026 · Updated 20 times
Summary
This early-phase trial tested the safety and how the body processes multiple doses of an experimental drug called NH102 in 40 healthy adults aged 18 to 45. Participants received either the drug or a placebo, and researchers monitored side effects, lab results, and vital signs. The goal was to gather safety data, not to treat depression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, 201108, China
Conditions
Explore the condition pages connected to this study.